Antisense drugs progressing through product pipelines.
Traynor
Kate
K
D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D017277:Drug Approval; D006801:Humans; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D013873:Thionucleotides / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D016376:Oligonucleotides, Antisense; D013873:Thionucleotides; C408162:oblimersen; C091346:fomivirsen